Outcomes in Localized Prostate Cancer: National Prostate Cancer Register of Sweden Follow-up Study

Abstract

A 10-year prostate cancer-specific mortality of 2.4% among patients with low-risk prostate cancer in the surveillance group indicates that surveillance may be a suitable treatment option for many patients with low-risk disease.